Navigation Links
Overlooked lymph nodes in rib cage have prognostic power for mesothelioma patients
Date:10/28/2013

SYDNEY, AUSTRALIAFor the first time, researchers from the Perelman School of Medicine at the University of Pennsylvania have shown the predictive power of a group of overlooked lymph nodes--known as the posterior intercostal lymph nodes--that could serve as a better tool to stage and ultimately treat patients with malignant pleural mesothelioma.

The findings were presented October 28 at the 15th World Conference on Lung Cancer.

Physicians look to lymph nodes to stage essentially all cancers, including mesothelioma. The presence or absence of metastatic cancer cells in lymph nodes affects prognosis and also typically dictates the optimal treatment strategy. But posterior intercostal lymph nodes, which are located between the ribs near the spine, have not been previously used to stage or guide treatment of malignant pleural mesothelioma or any other cancer.

In a retrospective study of 48 Penn Medicine patients undergoing radical pleurectomy for malignant pleural mesothelioma, Joseph S. Friedberg, MD, Chief of the Section of Thoracic Surgery at Penn Presbyterian Medical Center and Co-Director of the Penn Mesothelioma and Pleural Disease Program, and colleagues found that over half the patients had cancer metastatic to these lymph nodes and that, in some of these patients, those were the only lymph nodes containing metastatic cancer.

Patients who did not have cancer in the posterior intercostal lymph nodes had significantly longer overall survival rates, nearly two and half years longer, compared to those who did have cancer in the lymph nodes.

"I am unaware of any other group that is sampling these nodes. They are not currently part of the staging system for mesothelioma, or any other cancer for that matter," said Dr. Friedberg. "What we have shown here is that even though these lymph nodes are not described in relation to this cancer, they are highly significant."

The conclusion of the study was that surgeons should routinely biopsy these lymph nodes as part of any surgery-based treatment for mesothelioma and that these lymph nodes should be included in any revision of the mesothelioma staging system.

"Ultimately, it means that the presence or absence of cancer in these lymph nodes could help guide the treatment of pleural mesothelioma," said Dr. Friedberg.

This study is one of a 13 Penn Medicine studies and talks being presented at the International Association for the Study of Lung Cancer's 15th World Conference on Lung Cancer.


'/>"/>

Contact: Steve Graff
stephen.graff@uphs.upenn.edu
215-349-5653
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Fatal cholesterol disease overlooked and untreated
2. HypothyroidMom.com Advises Thyroid Hormone Is The Most Overlooked Treatment For Fibromyalgia
3. Is Menopause Overlooked in U.S. Medical Schools?
4. Sex Lives Often an Overlooked Casualty of Traumatic Brain Injury
5. Eczema Nonprofit Seeks to Shine New Light on Overlooked Condition
6. Overlooked ugly cholesterol causes heart disease
7. Cancer-Related Fatigue Often Overlooked, Study Finds
8. Eczema Non-Profit Seeks To Shine New Light On Overlooked Condition
9. Patient mental health overlooked by physician when a family member is present
10. Research shows genetic anti-inflammatory defect predisposes children to lymphoma
11. North American Seminars Introduces a New Physical Therapy Continuing Education Course Online, The Lymphedema Toolbox
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification ... pleased to announce the launch of the GFCP Scoop in response ... The purpose of the GFCP Scoop site is to keep the ...
(Date:4/29/2016)... New York, NY (PRWEB) , ... April 29, 2016 , ... New York City based ... surgery . This surgery is a very effective way to treat obstructive sleep apnea. Dr. ... , Orthognathic surgery is a procedure that involves one or both jaw bones. This ...
(Date:4/29/2016)... GA (PRWEB) , ... April 29, 2016 , ... ... the closing of a growth round of funding led by Eastside Partners, with ... support the company’s rapidly growing customer base and accelerate its technology and product ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... focused entirely on patients with cancer, today announced that Lynne Malestic, RN, of ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, ... animal line of probiotics, Petbiotics ™, as they fondly call them. As ... rescue groups networking for their non-profit organizations. Animal rescues across the nation face ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... April 28, 2016  While Abbott,s announced purchase ... company,s valve repair and stent business, healthcare research ... Abbott more firmly into patient monitoring.  Kalorama said ... growing device areas, with double-digit growth expected the ... Advanced Remote Patient Monitoring . Abbott ...
(Date:4/28/2016)... 28, 2016  Marking its one year anniversary ... ovarian cancer risk test, Color Genomics ... that highly impact the most common hereditary cancers ... Color Test analyzes hereditary cancer risks for breast, ... cancers. The Color Test is physician ordered and ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
Breaking Medicine Technology: